These results suggest a key role of SOX11-mediated PRDX2 upregulation, contributing to chemoresistance by neutralizing lethal ROS levels and probably activating oncogenic signaling pathways in MCL cells. Here, PRDX2 is linked to mantle cell lymphoma.